UY27754A1 - Formulación de aerosol para inhalación que contiene una sal de tiotropio. - Google Patents

Formulación de aerosol para inhalación que contiene una sal de tiotropio.

Info

Publication number
UY27754A1
UY27754A1 UY27754A UY27754A UY27754A1 UY 27754 A1 UY27754 A1 UY 27754A1 UY 27754 A UY27754 A UY 27754A UY 27754 A UY27754 A UY 27754A UY 27754 A1 UY27754 A1 UY 27754A1
Authority
UY
Uruguay
Prior art keywords
aerosol formulation
tiotropio
salt
inhalation containing
inhalation
Prior art date
Application number
UY27754A
Other languages
English (en)
Inventor
Drechsel Karin
Niklaus-Humke Barbara
Schmelzer Christel
Barth Petra
Original Assignee
Boehringer Ingelheim Pharma
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28458728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY27754(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma, Co Kg filed Critical Boehringer Ingelheim Pharma
Publication of UY27754A1 publication Critical patent/UY27754A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Nozzles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a una formulación de aerosol, exenta de gas propulsor, de una sal farmacéticamente aceptable de tiotropio, disuelta en agua. La formulación de acuerdo con la invención es apropiada, en especial, para nebulizar la sustancia activa por medio de un pulverizador, con el fin de administrar la sustancia activa mediante inhalación, en caso de presentarse las indicaciones de asma y/o COPD.
UY27754A 2002-04-11 2003-04-09 Formulación de aerosol para inhalación que contiene una sal de tiotropio. UY27754A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10216036A DE10216036A1 (de) 2002-04-11 2002-04-11 Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz

Publications (1)

Publication Number Publication Date
UY27754A1 true UY27754A1 (es) 2003-11-28

Family

ID=28458728

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27754A UY27754A1 (es) 2002-04-11 2003-04-09 Formulación de aerosol para inhalación que contiene una sal de tiotropio.

Country Status (33)

Country Link
EP (2) EP1496876B1 (es)
JP (1) JP2005531528A (es)
KR (1) KR100997219B1 (es)
CN (1) CN1309378C (es)
AR (1) AR039286A1 (es)
AT (1) ATE389391T1 (es)
AU (1) AU2003222791B2 (es)
BR (1) BR0309080A (es)
CA (1) CA2473815C (es)
CO (1) CO5611150A2 (es)
CY (1) CY1108133T1 (es)
DE (2) DE10216036A1 (es)
DK (1) DK1496876T3 (es)
EA (1) EA007228B1 (es)
EC (1) ECSP045358A (es)
ES (1) ES2303897T3 (es)
HK (1) HK1078793A1 (es)
HR (1) HRP20040932B1 (es)
ME (1) ME00359B (es)
MX (1) MXPA04009818A (es)
MY (1) MY137249A (es)
NO (1) NO334915B1 (es)
PE (1) PE20030970A1 (es)
PL (1) PL371204A1 (es)
PT (1) PT1496876E (es)
RS (1) RS50923B (es)
SA (1) SA03240192B1 (es)
SI (1) SI1496876T1 (es)
TW (1) TWI344851B (es)
UA (1) UA78994C2 (es)
UY (1) UY27754A1 (es)
WO (1) WO2003084519A2 (es)
ZA (1) ZA200405721B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG137859A1 (en) 2003-11-03 2007-12-28 Boehringer Ingelheim Int Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
NZ566399A (en) * 2005-08-06 2011-07-29 Boehringer Ingelheim Int Use of tiotropium salts in the treatment of severe persistant asthma
US20070088030A1 (en) 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
EP1905440A1 (de) * 2006-09-06 2008-04-02 Boehringer Ingelheim Pharma GmbH & Co. KG Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen
EP2044967A1 (de) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Zerstäuber
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
RU2493827C1 (ru) * 2012-10-03 2013-09-27 Шолекс Девелопмент Гмбх Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида
WO2015065219A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Раствор ипратропия бромида
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
GB201507686D0 (en) * 2015-05-05 2015-06-17 Norton Healthcare Ltd A stable tiotropium nebuliser solution
AU2017363041A1 (en) * 2016-11-16 2019-04-11 Glenmark Specialty S.A. Nebulized tiotropium
US20210290568A1 (en) * 2020-03-19 2021-09-23 Cai Gu Huang Inhalable formulation of a solution containing levalbuterol tartrate
CN114259481A (zh) * 2021-11-26 2022-04-01 南京华盖制药有限公司 一种奥达特罗复方吸入溶液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
DE19536903C2 (de) 1995-10-04 1998-09-10 Boehringer Ingelheim Int Vorrichtung zum Haltern eines fluidischen Bauteils
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19545226C1 (de) 1995-12-05 1997-06-19 Boehringer Ingelheim Int Sperrspannwerk für einen federbetätigten Abtrieb
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19742439C1 (de) 1997-09-26 1998-10-22 Boehringer Ingelheim Int Mikrostrukturiertes Filter
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
EP1837021A3 (de) * 2000-10-31 2008-03-19 Boehringer Ingelheim Pharma GmbH & Co. KG Inhalative Lösungsformulierung mit einem Tiotropiumsalz

Also Published As

Publication number Publication date
AU2003222791A1 (en) 2003-10-20
PL371204A1 (en) 2005-06-13
CA2473815A1 (en) 2003-10-16
CO5611150A2 (es) 2006-02-28
SI1496876T1 (sl) 2008-08-31
ZA200405721B (en) 2006-05-31
EP1949892A1 (de) 2008-07-30
PT1496876E (pt) 2008-04-15
RS87904A (en) 2006-12-15
SA03240192B1 (ar) 2008-01-09
ES2303897T3 (es) 2008-09-01
WO2003084519A3 (de) 2003-12-24
HRP20040932A2 (en) 2005-02-28
BR0309080A (pt) 2005-02-22
KR100997219B1 (ko) 2010-11-29
DE50309414D1 (de) 2008-04-30
DK1496876T3 (da) 2008-06-02
AR039286A1 (es) 2005-02-16
DE10216036A1 (de) 2003-10-23
MY137249A (en) 2009-01-30
EP1496876A2 (de) 2005-01-19
HRP20040932B1 (hr) 2013-04-30
ECSP045358A (es) 2004-11-26
UA78994C2 (uk) 2007-05-10
ATE389391T1 (de) 2008-04-15
TW200401653A (en) 2004-02-01
NO20044001L (no) 2004-10-27
EA200401305A1 (ru) 2005-06-30
MXPA04009818A (es) 2004-12-13
NO334915B1 (no) 2014-07-14
CN1309378C (zh) 2007-04-11
EP1496876B1 (de) 2008-03-19
ME00359B (me) 2011-10-10
CA2473815C (en) 2011-06-14
HK1078793A1 (en) 2006-03-24
CY1108133T1 (el) 2014-02-12
MEP54308A (en) 2011-05-10
KR20040097322A (ko) 2004-11-17
EA007228B1 (ru) 2006-08-25
RS50923B (sr) 2010-08-31
WO2003084519A2 (de) 2003-10-16
AU2003222791B2 (en) 2008-09-25
JP2005531528A (ja) 2005-10-20
CN1646108A (zh) 2005-07-27
PE20030970A1 (es) 2004-01-13
TWI344851B (en) 2011-07-11

Similar Documents

Publication Publication Date Title
ECSP045358A (es) Formulacion de aerosol para inhalación que contiene una sal de tiotripio
DE60308997D1 (de) Formulierungen zur inhalation
ES2176355T3 (es) Formulaciones de aerosol de peptidos y proteinas.
ECSP088404A (es) Nuevos derivados de imidazo[4,5-b]piridina como inhibidores de la glucógeno sintasa quinasa 3, para uso en el tratamiento de demencia y trastornos neurodegenerativos
IT1317846B1 (it) Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
ATE554746T1 (de) Pharmazeutische zusammensetzungen mit cyclosporin
DE60019167D1 (de) Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
UY27740A1 (es) Nuevos compuestos
BRPI0509795A (pt) composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, uso do composto ou sal farmacologicamente aceitável do mesmo, e, método para promover osteogênese, supressão de ressorção óssea e/ou melhoramento da densidade óssea
AR038641A1 (es) Formulacion superfina de formoterol
AR019690A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
RS52940B (en) PHARMACEUTICAL FORMULATIONS OF SOLUTION FOR MEASURED DOSES OF PRESSURE INHALATORS
UY29905A1 (es) Formulación farmacéutica de absorción oral y su método de administración
DE60031504D1 (de) Fluticasonpropionat arzneizubereitung
WO2007020204A3 (en) Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
AR089302A1 (es) Un medicamento inhalable
BR0317340A (pt) Formulações de hfc em solução contendo tiotrópio
AR040450A1 (es) Formulacion superfina de salmeterol
HUP0302036A2 (hu) Glükokortikoidot tartalmazó készítmény bronchopulmonális betegségek kezelésére
ECSP088732A (es) Aerosoles dosificadores para la administración de preparaciones farmacéuticas
AR054230A1 (es) Formulaciones farmaceuticas en aerosol para inhaladores de cartucho presurizados que comprenden un agente secuestrante
GT200300017A (es) Sistema de suministro osmotico
PE20030092A1 (es) Formulacion de una solucion de inhalacion con una sal de tiotropio
ES2180446B1 (es) Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil.
WO2008093358A3 (en) Aqueous topical solution containing olopatadine

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20151109